Advertisement

L’or Ensé advertisement
L’or Ensé advertisement
L’or Ensé advertisement

Advertisement

L’or Ensé advertisement

Kirkland Advises Frazier Life Sciences on $1.1 Billion Public Fund Raise

Kirkland & Ellis has advised Frazier Life Sciences on raising over $1.1 billion in capital commitments for the Frazier Life Sciences Public Fund.

Kirkland & Ellis

·

·

1 min read

Kirkland Advises Frazier Life Sciences on $1.1 Billion Public Fund Raise

Kirkland & Ellis has advised Frazier Life Sciences on raising over $1.1 billion in capital commitments for the Frazier Life Sciences Public Fund. New and existing investors backed the oversubscribed raise, which takes the vehicle to roughly $2.8 billion raised since its launch as a dedicated fund in 2021.

The long-only fund is built to handle volatility and liquidity in small- and mid-cap public biotech companies. It can also invest in later-stage private companies through crossover financings, in line with Frazier’s long-standing focus on innovative therapeutics.

The Kirkland investment funds team included Katie St. Peters, Dan Applebaum, Nathan Jimenez, Emily Hartney and Beth Jones.

Share

More in Fund Raises

Newsletter

Subscribe to Market Insights

The IFLD newsletter on the investment funds legal market, sent by email.

Advertisement

L’or Ensé advertisement